🔎 Trials Near Me

Akèy › Hidradénite suppurative › Massachusetts › Boston

Etid klinik pou Hidradénite suppurative nan Boston, MA

9 etid pou Hidradénite suppurative ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Ap rekriteFaz 2
  • Beth Israel Deaconess Medical Center - Boston- Site Number : 8400001, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07225569

Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa

Ap rekriteFaz 1
  • Clinical Site 3, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07828860

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Ap rekriteFaz 1
  • Up0122 104, Boston
Laj 18 ak plis · Fanm · Mizajou Sep 18, 2026 · NCT06888193

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

Ap rekriteFaz 3
  • Investigative Site US030, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06855498

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Ap rekriteFaz 2
  • Boston Childrens Hospital, Boston
Laj 12 a 17 · Tout sèks · Mizajou Aug 6, 2026 · NCT07213973

A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

Ap rekriteFaz 2
  • Beth Israel Deaconess Medical Center, Boston
Laj 18 a 70 · Tout sèks · Mizajou Jul 22, 2026 · NCT07384975

The Safety and Efficacy of Roflumilast Foam in HS

Ap rekriteFaz 2
  • Beth Israel Deaconess Medical Center, Boston
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2026 · NCT07263230

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Ap rekriteEtid obsèvasyon
  • Tufts University, Boston
  • Massachusetts General Hospital, Boston
  • Brigham and Women's Hospital, Boston
Laj 18 a 71 · Tout sèks · Mizajou Apr 16, 2026 · NCT07123038

A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

Ap rekriteFaz 2
  • Beth Israel Deaconess Medical Center, Boston
Laj 18 ak plis · Tout sèks · Mizajou Mar 6, 2026 · NCT07244263

Etid Hidradénite suppurative nan lòt vil

Lòt etid nan Boston

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.